No specific laws identified for this ruling.
The Court of Appeals for the Federal Circuit affirmed the district court's judgment that U.S. Patent No. 6,787,531 for micronized drospirenone oral contraceptive was invalid as obvious under 35 U.S.C. § 103, holding that it would have been obvious to try a normal pill formulation based on prior art and known techniques.
This summary was generated to explain the ruling in plain English and is not legal advice.
Court rulings like this one are useful, but every situation is different. Take 2 minutes to see which laws may protect you — it's free, private, and no account is required to start.
This ruling information is sourced from public court records via CourtListener.com. It is provided for informational and educational purposes only and does not constitute legal advice.